Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on a Board of Directors meeting held on December 19, 2019. The document serves as a summary of minutes regarding corporate governance actions and the authorization of specific financial instruments, rather than a comprehensive financial results report for the period ending December 31, 2019.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The only quantitative financial data disclosed relates to the authorized equity swap program:
- Outstanding Shares: 4,348,880,682
- Treasury Shares: 3,091,790
- Authorized Equity Swap Exposure: Up to 80 million common shares (or ADRs).
- Authorized Swap Limit Value: Up to R$ 1.5 billion.
- Total Potential Exposure: Including unsettled agreements from prior approvals, total exposure may reach 217,014,453 common shares.
Material Changes
The filing details two primary resolutions passed by the Board:
- Equity Swap Authorization: The Board approved the execution of equity swap agreements with financial institutions. These are financially settled derivatives designed to hedge against stock price volatility affecting the company's share-based payment programs. The agreements allow for a maximum term of 18 months (until June 19, 2021).
- Committee Appointment: Mr. Carlos Emmanuel Joppert Ragazzo was elected to the Related Parties and Antitrust Conducts Committee to fill a vacancy left by the resignation of Mr. Bolívar Moura Rocha on October 2, 2019. His term lasts until the Annual Shareholders' Meeting resolving the 2019 financial statements.
Guidance, Outlook, and Risks
Management Commentary: The Board affirmed that the company's current financial situation is compatible with these operations. They stated confidence that the equity swaps will not impair the company's ability to meet creditor obligations or pay mandatory, fixed, or minimum dividends.
Risks and Contingencies:
- Counterparty Termination: The derivative instruments may allow financial institutions to terminate agreements if the share price depreciates by 50% or more.
- Settlement Terms: The company retains the option to terminate contracts at any time at its sole discretion.
- Related Parties: Counterparties will not be related parties to the company.
Unusual Items: The filing notes that the equity swap transactions involve exclusive financial settlement; no physical purchase or disposal of shares or ADRs will occur.
Investor Verification Checklist
- Verify the total outstanding share count (4,348,880,682) against the latest 20-F annual report.
- Confirm the status of the Related Parties and Antitrust Conducts Committee membership following the appointment of Mr. Ragazzo.
- Monitor future filings for the actual execution and settlement of the authorized R$ 1.5 billion equity swap program.
- Review the company's 2019 Annual Report (Form 20-F) for actual revenue, profit, and cash flow data, as this 6-K does not contain those figures.